Skip to main content
Year archive

UCB — 2023 filings

All 37 regulatory filings released by UCB (UCB) in 2023, sourced directly from the official regulator.

37 Filings
2023 Period
2023 filings (37)
Filing Released Lang
PRWellingtonENG-171123.pdf
Major Shareholding Notification
2023-11-23 English
CDPWellingtonFR-171123.pdf
Major Shareholding Notification
2023-11-23 French
PBWellingtonNL-171123.pdf
Major Shareholding Notification
2023-11-23 Dutch
Approval Zilu 18.10.23.pdf
Regulatory Filings
2023-10-18 English
UCB PR Bimzelx FDA Approval Oct 18 2023 ENG.pdf
Regulatory Filings
2023-10-18 English
UCB Half-Year 2023 Report - EN - final.pdf
Interim / Quarterly Report H1 2023
2023-07-27 English
2023_Half-Year_Report-FR.pdf
Interim / Quarterly Report H1 2023
2023-07-27 French
2023_Half-Year_Report-NL.pdf
Interim / Quarterly Report H1 2023
2023-07-27 Dutch
UCB PR rozanolixizumab FDA approval June 27 2023 ENG.pdf
Regulatory Filings
2023-06-27 English
Regulated Inside - 26.06.23.pdf
Regulatory Filings
2023-06-26 English
230519 PR Transparency notification FMR LLC.pdf
Major Shareholding Notification
2023-05-26 English
230519 - CdP Notification de transparence FMR LLC.pdf
Declaration of Voting Results & Voting Rights Announcements
2023-05-26 French
230519 PB Transparantieverklaring FMR LLC.pdf
Major Shareholding Notification
2023-05-26 Dutch
Minutes AGM 27.04.23 - ENG.pdf
AGM Information
2023-05-12 English
PV AGO 27.04.202 - FR.pdf
AGM Information
2023-05-12 French
Notulen AVA 27.04.23 - NL.pdf
AGM Information
2023-05-12 Dutch
UCB SA_Board of Directors report_12_2022 EN Final (web).pdf
Management Reports FY 2022
2023-03-24 English
UCB SA_Board of Directors report_12_2022 FR Final (web).pdf
Management Reports
2023-03-24 French
UCB SA_Board of Directors report_12_2022 NL Final (web).pdf
Management Reports
2023-03-24 Dutch
Proxy General Meeting 27 April 2023- ENG-V11.pdf
Proxy Solicitation & Information Statement
2023-03-24 English
Proxy General Meeting 27 avril 2023 - FR- V11.pdf
AGM Information
2023-03-24 French
Proxy General Meeting 27 April 2023 - NL - V11.pdf
AGM Information
2023-03-24 Dutch
ENG - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information
2023-03-24 English
FR - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information
2023-03-24 French
NL - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information
2023-03-24 Dutch
230303 - Acquisition of own shares_ENG (final) - Copy.pdf
Transaction in Own Shares
2023-03-03 English
230303 - Rachat d'actions propres_FR (final) - Copy.pdf
Transaction in Own Shares
2023-03-03 French
230303 - Verwerving van eigen aandelen_NL (final) - Copy.pdf
Transaction in Own Shares
2023-03-03 Dutch
2022_Full-Year_Integrated_Annual_Report_0.pdf
Annual Report FY 2022
2023-02-22 English
2022_Full-Year_Integrated_Annual_Report-FR.pdf
Annual Report FY 2022
2023-02-22 French
2022_Full-Year_Integrated_Annual_Report-NL.pdf
Annual Report FY 2022
2023-02-22 Dutch
21380029O1RSZIAVOR95-2022-12-31-en.xhtml
Annual Report FY 2022
2023-02-22 English
21380029O1RSZIAVOR95-2022-12-31-en (1).zip
Annual Report (ESEF) FY 2022
2023-02-22 English
21380029O1RSZIAVOR95-2022-12-31-fr.xhtml
Annual Report FY 2022
2023-02-22 French
21380029O1RSZIAVOR95-2022-12-31-fr.zip
Annual Report (ESEF) FY 2022
2023-02-22 French
21380029O1RSZIAVOR95-2022-12-31-nl.xhtml
Annual Report FY 2022
2023-02-22 Dutch
21380029O1RSZIAVOR95-2022-12-31-nl.zip
Annual Report (ESEF) FY 2022
2023-02-22 Dutch